Influence of a priori Information, Designs, and Undetectable Data on Individual Parameters Estimation and Prediction of Hepatitis C Treatment Outcome. (17th July 2013)

• Record Type: Journal Article
• Authors: Nguyen, THT; Guedj, J; Yu, J; Levi, M; Mentré, F
• Is Part Of: CPT: pharmacometrics & systems pharmacology. Volume 2:Number 7(2013)
• Page Start: 1
• Page End: 9
• Publication Date: 2013-07-17
• Subjects: Pharmacokinetics -- Periodicals; Pharmacology -- Periodicals; Pharmacokinetics; Periodicals; 615.05
• DOI: 10.1038/psp.2013.31
• Languages: English
• ISSNs: 2163-8306

Abstract

Abstract : Hepatitis C viral kinetic analysis based on nonlinear mixed effect models can be used to individualize treatment. For that purpose, it is necessary to obtain precise estimation of individual parameters. Here, we evaluated by simulation the influence on Bayesian individual parameter estimation and outcome prediction of a priori information on population parameters, viral load sampling designs, and methods for handling data below detection limit (BDL). We found that a precise estimation of both individual parameters and treatment outcome could be obtained using as few as six measurements in the first month of therapy. This result remained valid even when incorrect a priori information on population parameters was set as long as the parameters were identifiable and BDL data were properly handled. However, setting wrong values for a priori population parameters could lead to severe estimation/prediction errors if BDL data were ignored and not properly accounted in the likelihood function. CPT: Pharmacometrics & Systems Pharmacology (2013) 2, e56; doi:10.1038/psp.2013.31 ; published online 17 July 2013